CYTENA and ExcellGene to Develop Automated Workflows for Biotherapeutics Cell Line Development
Today, CYTENA, a BICO group company (Nasdaq Stockholm: BICO) and a leading provider of high-precision instruments for handling biological cells, has entered a collaboration agreement with ExcellGene SA, a leading biologics CDMO that manufactures recombinant proteins. Together, the companies will streamline cell ...
Source: pharmiweb.com